Seema Mody is a global markets reporter for CNBC, located at the network's Global Headquarters in Englewood Cliffs, N.J. Most recently, Mody was co-anchor for "Worldwide Exchange" based in London. She joined CNBC in July 2011 as a reporter focusing on stories that impact Wall Street as well as tracking the tech and IPO market from the NASDAQ. Mody also hosted a "Trading the Twicker" segment for "Fast Money."
Previously, Mody was an anchor and reporter at CNBC-TV18 in Mumbai, India where she covered India's economic boom. She co-anchored two programs for the station, "Power Breakfast" and "After the Bell," as well as co-produced and anchored special features on "Mumbai Fashion Week" and "Tech Toyz." While at CNBC-TV18, Mody also reported on private equity deals and M&A activity across India exclusively interviewing global private equity heads, including Warburg Pincus CEO Chip Kaye. Mody provided India daily market updates on CNBC World's "Capital Connection" and "Cash Flow."
Follow Seema Mody on Twitter @SeemaCNBC.
CNBC's Seema Mody reports on all the market moving events in Europe today.
CNBC's Seema Mody takes a closer look at fourth-quarter market expectations. Jeffrey Kleintop, Charles Schwab chief global investment strategist, Margaret Vitrano, ClearBridge Investments portfolio manager, weigh in and share their Q4 game plans ahead of the elections.
CNBC's Seema Mody reports on all the market moving events in Europe today, including U.K. Prime Minister Theresa May announcing she intends to begin Brexit talks by March.
CNBC's Seema Mody reports on all the market moving events in Europe today, including a rebound in Deutsche Bank.
Och-Ziff Capital Management has settled with the Department of Justice over criminal charges for $213 million, in addition to an SEC settlement.
Earnings are out for Costco. CNBC's Seema Mody reports the details. CNBC senior markets commentator Mike Santoli and Stephanie Link, TIAA Global Asset Management, weigh in.
CNBC's Seema Mody reports that Och-Ziff Capital has agreed to pay nearly $200 million to the SEC to settle civil charges for foreign corrupt practices.
Intra-Cellular Therapies shares plunge 68 percent after study results on a schizophrenia drug trial. CNBC's Seema Mody reports.